Marinus Pharmaceuticals, Inc

(NASDAQ:MRNS)

Latest On Marinus Pharmaceuticals, Inc (MRNS):

Date/Time Type Description Signal Details
2023-05-26 13:55 ESTNewsMarinus' seizure drug Ztalmy inches toward EU approval with EMA nodN/A
2023-05-11 22:24 ESTNewsMarinus Pharmaceuticals, Inc. (MRNS) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 08:12 ESTNewsMarinus Pharmaceuticals GAAP EPS of -$0.67 beats by $0.13, revenue of $10.38M beats by $5.47MN/A
2023-03-31 23:23 ESTNewsMarinus launches $375M mixed shelf offering - filingN/A
2023-03-22 14:13 ESTNewsMarinus ganaxolone for severe epilepsy gets FDA orphan drug statusN/A
2023-03-08 12:36 ESTNewsMarinus Pharmaceuticals, Inc. (MRNS) Q4 2022 Earnings Call TranscriptN/A
2023-03-07 22:04 ESTNewsMarinus Pharmaceuticals GAAP EPS of -$0.76 misses by $0.16, revenue of $7.16M misses by $1.99MN/A
2023-03-07 07:13 ESTNewsMarinus Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-01-20 20:10 ESTNewsMarinus Pharmaceuticals initiated at outperform at RBC on epilepsy drugN/A
2022-11-18 00:18 ESTNewsMarinus Pharmaceuticals taps CEO Scott Braunstein as chairmanN/A
2022-11-18 00:18 ESTNewsMarinus to get $10M upfront in license pact with Tenacia to develop CNS therapies in ChinaN/A
2022-11-08 15:51 ESTNewsMarinus Pharmaceuticals shares slide 18% on $60M securities offeringN/A
2022-11-08 15:49 ESTNewsMarinus Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-08 15:48 ESTNewsMarinus Pharmaceuticals, Inc. (MRNS) Q3 2022 Earnings Call TranscriptN/A
2022-11-07 21:56 ESTNewsMarinus Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-07 21:55 ESTNewsMarinus PharmaceuticalsEPS of $1.89, revenue of $2.34M misses by $23.42MN/A
2022-11-07 21:55 ESTNewsMarinus Pharmaceuticals stock drops 19% aftermarket on proposed public offeringN/A
2022-10-31 21:13 ESTNewsMarinus Pharmaceuticals enters $32.5M interest financing agreement with Sagard Healthcare PartnersN/A
2022-09-22 20:41 ESTNewsUS government uses contract option for Marinus' seizure therapy ganaxoloneN/A
2022-09-22 20:39 ESTNewsMarinus Pharmaceuticals: Positive News Flow Of NoteN/A
2022-08-30 07:22 ESTNewsMarinus Pharma closes on sale of a U.S. FDA priority review voucher for $110MN/A
2022-08-12 05:22 ESTNewsMarinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 12:40 ESTNewsMarinus Pharmaceuticals GAAP EPS of -$1.06 misses by $0.37, revenue of $1.8M misses by $0.51MN/A
2022-08-10 20:29 ESTNewsMarinus Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-28 11:29 ESTNewsMarinus Pharma announces U.S. commercial launch of seizure therapy ZtalmyN/A
2022-07-14 08:28 ESTNewsMarinus stock rises as it sells priority review voucher for $110MN/A
2022-06-01 17:57 ESTNewsMarinus granted additional time in European review of seizure candidateN/A
2022-05-24 23:26 ESTNewsMarinus Pharmaceuticals (MRNS) Investor Presentation - SlideshowN/A
2022-05-12 20:44 ESTNewsMarinus Pharmaceuticals GAAP EPS of -$0.52 beats by $0.33, revenue of $14.19M beats by $11.91MN/A
2022-05-12 20:43 ESTNewsMarinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-12 02:15 ESTNewsMarinus Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-05-06 05:21 ESTNewsMarinus stock rises premarket after resuming phase 3 RAISE trial for prolonged seizuresN/A
2022-05-06 05:21 ESTNewsRevisiting Marinus PharmaceuticalsN/A
2022-04-01 09:22 ESTNewsMarinus gets $30M under Oaktree credit facility following Ztalmy US approvalN/A
2022-03-23 07:25 ESTNewsMarinus Pharmaceuticals higher as Truist and JMP raises price target after FDA approved ZTALMYN/A
2022-03-23 07:25 ESTNewsMarinus Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-21 21:32 ESTNewsMarinus Pharmaceuticals GAAP EPS of -$0.77 misses by $0.02, revenue of $1.52M misses by $1.98MN/A
2022-03-21 21:31 ESTNewsMarinus Pharma falls as Q4 earnings miss adds to trial delaysN/A
2022-03-21 21:31 ESTNewsMarinus Pharmaceuticals, Inc. (MRNS) CEO Dr. Scott Braunstein on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-19 01:49 ESTNewsMarinus Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-03-19 01:48 ESTNewsMarinus Pharma spikes on FDA approval for seizure therapyN/A
2022-02-28 15:35 ESTNewsMarinus Stock Slides To 18-Month Low, Upcoming PDUFA May Offer RedemptionN/A
2022-02-23 22:02 ESTNewsMarinus slips to a 52-week low as analysts react to delays for clinical studiesN/A
2022-02-23 03:23 ESTNewsMarinus falls after announcing delay for clinical programs citing Omicron impactN/A
2021-12-03 17:35 ESTNewsData shows extended benefit of Marinus epilepsy treatment ganaxolone up to a yearN/A
2021-11-10 12:14 ESTNewsMarinus Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-10 12:14 ESTNewsMarinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 13:08 ESTNewsMarinus Pharmaceuticals EPS beats by $0.12, beats on revenueN/A
2021-11-08 15:27 ESTNewsMarinus Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-09-22 00:52 ESTNewsFDA accepts Marinus' ganaxolone NDA for review under Priority statusN/A

About Marinus Pharmaceuticals, Inc (MRNS):

Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat rare seizure disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including intravenous (IV) and oral for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ganaxolone product candidate, acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for status epilepticus, cyclin dependent kinase like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, and postpartum depression. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

MRNS Quotes by TradingView

See Advanced Chart

General

  • Name Marinus Pharmaceuticals, Inc
  • Symbol MRNS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 65
  • Last Split Factor1:4
  • Last Split Date2020-09-23
  • Fiscal Year EndDecember
  • IPO Date2014-07-31
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.marinuspharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 2513.8
  • Price/Book (Most Recent Quarter) 8.42
  • Enterprise Value Revenue 338.01
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.95
  • Next Year EPS Estimate -$2.38
  • Next Quarter EPS Estimate -$0.45
  • Operating Margin -3954%
  • Return on Assets -34%
  • Return on Equity -60%
  • Revenue 1.72 million
  • Earnings Per Share -$0.98
  • Revenue Per Share $0.06
  • Gross Profit -25387000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 597.22 million
  • EBITDA -45371000
  • PE Ratio -0.52
  • Analyst Target Price $29.78
  • Book Value Per Share $3.63
View More

Share Statistics

  • Shares Outstanding 36.58 million
  • Shares Float 24.59 million
  • % Held by Insiders 255%
  • % Held by Institutions 71.12%
  • Shares Short 4.23 million
  • Shares Short Prior Month 4.18 million
  • Short Ratio 14.35
  • Short % of Float 12%
  • Short % of Shares Outstanding 12%
View More

Technicals

  • Beta 1.58
  • 52 Week High $20.04
  • 52 Week Low $5.92
  • 50 Day Moving Average 15.09
  • 200 Day Moving Average 13.48
View More

Dividends

  • Dividend Date 2020-09-23
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Marinus Pharmaceuticals, Inc (MRNS) Dividend Calendar:

MRNS's last dividend payment was made to shareholders on September 23, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Marinus Pharmaceuticals, Inc (MRNS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$N/A-$0.51-$0.50-1.19%
2020-09-302020-11-09$171000-$0.51-$0.6015.28%
2020-06-302020-08-06$N/A-$0.64-$0.8020%
2020-03-312020-05-04$N/A-$1.28-$0.65-96.92%
2019-12-312020-03-16$N/A-$1.00-$0.83-19.86%
2019-09-302019-11-06$N/A-$1.04-$0.95-9.64%
2019-06-302019-08-08$N/A-$0.96-$0.95-1.4%
2019-03-312019-05-01$N/A-$0.96-$0.86-11.63%
2018-12-312019-03-11$N/A-$0.96-$1.036.34%
2018-09-302018-10-29$N/A-$1.08-$0.84-28.57%
2018-06-302018-08-02$N/A-$0.96-$0.62-54.84%
2018-03-312018-05-02$N/A-$0.60-$0.658.16%
2017-12-312018-03-06$N/A-$0.80-$0.62-29.03%
2017-09-302017-10-31$N/A-$0.60-$0.6811.76%
2017-06-302017-08-01$N/A-$0.84-$1.0822.22%
2017-03-312017-05-01$N/A-$1.04-$1.2818.75%
2016-12-312017-03-13$N/A-$1.24-$1.3810.14%
2016-09-302016-11-03$N/A-$1.32-$1.9231.25%
2016-06-302016-08-09$N/A-$1.84-$1.53-20%
2016-03-312016-05-02$N/A-$1.48-$1.649.76%
2015-12-312016-03-07$N/A-$1.80-$1.18-52.54%
2015-09-302015-10-29$N/A-$0.35-$0.5131.37%
2015-06-302015-08-04$N/A-$0.37-$0.5127.45%
2015-03-312015-05-11$N/A-$0.50-$0.47-6.38%
2014-12-312015-03-12$N/A-$0.26-$0.3933.33%
2014-09-302014-11-13$N/A-$0.22-$0.4551.11%
2014-06-302014-09-03$N/A-$1.28

Marinus Pharmaceuticals, Inc (MRNS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Marinus Pharmaceuticals, Inc (MRNS) Chart:

Marinus Pharmaceuticals, Inc (MRNS) News:

Below you will find a list of latest news for Marinus Pharmaceuticals, Inc (MRNS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Marinus Pharmaceuticals, Inc (MRNS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-1711.1CALL0 30TRUE00
2025-04-1720.65CALL4 35155.61FALSE0.650
2025-04-1730CALL0 00FALSE00
2025-04-1740CALL0 00FALSE00
2025-04-1750CALL0 00FALSE00
2025-04-1710PUT0 00FALSE00
2025-04-1721PUT0 5141.18TRUE00
2025-04-1730PUT0 0146.47TRUE00
2025-04-1740PUT0 0135.3TRUE00
2025-04-1750PUT0 0259.54TRUE00

Latest MRNS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST10$4.075
Jun 13, 2022 7:59 PM EST10$4.08
Jun 13, 2022 7:59 PM EST20$4.08
Jun 13, 2022 7:59 PM EST16$4.08
Jun 13, 2022 7:59 PM EST3$4.08

Marinus Pharmaceuticals, Inc (MRNS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920074237/0001104659-20-074237-index.htm
2020-05-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1267813/000000000020003918/0000000000-20-003918-index.htm
2020-07-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1267813/000000000020006484/0000000000-20-006484-index.htm
2018-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000003877718000006/0000038777-18-000006-index.htm
2019-03-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000003877719000103/0000038777-19-000103-index.htm
2018-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000005341718000041/0000053417-18-000041-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000005341719000039/0000053417-19-000039-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000005341720000047/0000053417-20-000047-index.htm
2017-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm
2018-01-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000090266418000144/0000902664-18-000144-index.htm
2019-01-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000090266419000380/0000902664-19-000380-index.htm
2019-12-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000090266419004643/0000902664-19-004643-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000090266420000490/0000902664-20-000490-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000090266420001117/0000902664-20-001117-index.htm
2017-12-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000090445417000712/0000904454-17-000712-index.htm
2018-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000090445418000049/0000904454-18-000049-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000090445419000270/0000904454-19-000270-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000090445420000030/0000904454-20-000030-index.htm
2020-09-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1267813/000090445420000638/0000904454-20-000638-index.htm
2020-11-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000090445420000703/0000904454-20-000703-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000093583618000131/0000935836-18-000131-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000101359420000175/0001013594-20-000175-index.htm
2018-12-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1267813/000104746918007592/0001047469-18-007592-index.htm
2018-12-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1267813/000104746918007641/0001047469-18-007641-index.htm
2019-12-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1267813/000104746919006783/0001047469-19-006783-index.htm
2019-12-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1267813/000104746919006827/0001047469-19-006827-index.htm
2020-05-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1267813/000104746920003242/0001047469-20-003242-index.htm
2020-05-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1267813/000104746920003267/0001047469-20-003267-index.htm
2017-12-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465917072520/0001104659-17-072520-index.htm
2017-12-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465917072522/0001104659-17-072522-index.htm
2018-01-224/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918003364/0001104659-18-003364-index.htm
2018-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918003365/0001104659-18-003365-index.htm
2018-01-224/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918003367/0001104659-18-003367-index.htm
2018-01-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918004809/0001104659-18-004809-index.htm
2018-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918004810/0001104659-18-004810-index.htm
2018-01-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918004812/0001104659-18-004812-index.htm
2018-01-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918004813/0001104659-18-004813-index.htm
2018-01-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918004814/0001104659-18-004814-index.htm
2018-01-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918004815/0001104659-18-004815-index.htm
2018-01-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918004816/0001104659-18-004816-index.htm
2018-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465918025843/0001104659-18-025843-index.htm
2018-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465918055332/0001104659-18-055332-index.htm
2018-09-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465918057807/0001104659-18-057807-index.htm
2018-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465918071355/0001104659-18-071355-index.htm
2018-12-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465918071840/0001104659-18-071840-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465918071971/0001104659-18-071971-index.htm
2018-12-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465918073125/0001104659-18-073125-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919004457/0001104659-19-004457-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919004459/0001104659-19-004459-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919011608/0001104659-19-011608-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919011635/0001104659-19-011635-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919011636/0001104659-19-011636-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919011637/0001104659-19-011637-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919011638/0001104659-19-011638-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919011639/0001104659-19-011639-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919011640/0001104659-19-011640-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919011641/0001104659-19-011641-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919014829/0001104659-19-014829-index.htm
2019-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919016324/0001104659-19-016324-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919016364/0001104659-19-016364-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919027184/0001104659-19-027184-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919027802/0001104659-19-027802-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919030563/0001104659-19-030563-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919041464/0001104659-19-041464-index.htm
2019-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919044907/0001104659-19-044907-index.htm
2019-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919044912/0001104659-19-044912-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919044913/0001104659-19-044913-index.htm
2019-08-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919047142/0001104659-19-047142-index.htm
2019-08-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919047144/0001104659-19-047144-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919051485/0001104659-19-051485-index.htm
2019-10-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919053242/0001104659-19-053242-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919055267/0001104659-19-055267-index.htm
2019-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919057204/0001104659-19-057204-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919061665/0001104659-19-061665-index.htm
2019-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919063472/0001104659-19-063472-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919070786/0001104659-19-070786-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919071737/0001104659-19-071737-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919072272/0001104659-19-072272-index.htm
2019-12-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919072560/0001104659-19-072560-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919072570/0001104659-19-072570-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919072572/0001104659-19-072572-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465919072574/0001104659-19-072574-index.htm
2019-12-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465919073914/0001104659-19-073914-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920003094/0001104659-20-003094-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920003095/0001104659-20-003095-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920003097/0001104659-20-003097-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920003098/0001104659-20-003098-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920003099/0001104659-20-003099-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920003100/0001104659-20-003100-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920003102/0001104659-20-003102-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920009947/0001104659-20-009947-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920021720/0001104659-20-021720-index.htm
2020-02-20PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920023425/0001104659-20-023425-index.htm
2020-03-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920027545/0001104659-20-027545-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920037409/0001104659-20-037409-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920042426/0001104659-20-042426-index.htm
2020-04-29S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1267813/000110465920053331/0001104659-20-053331-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920055872/0001104659-20-055872-index.htm
2020-05-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1267813/000110465920059524/0001104659-20-059524-index.htm
2020-05-11S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1267813/000110465920059534/0001104659-20-059534-index.htm
2020-05-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1267813/000110465920060846/0001104659-20-060846-index.htm
2020-05-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1267813/000110465920063156/0001104659-20-063156-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920066366/0001104659-20-066366-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920067778/0001104659-20-067778-index.htm
2020-06-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920074162/0001104659-20-074162-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920074168/0001104659-20-074168-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920074237/0001104659-20-074237-index.htm
2020-07-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1267813/000110465920082429/0001104659-20-082429-index.htm
2020-07-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920082467/0001104659-20-082467-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920082491/0001104659-20-082491-index.htm
2020-07-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1267813/000110465920084038/0001104659-20-084038-index.htm
2020-07-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1267813/000110465920084948/0001104659-20-084948-index.htm
2020-07-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1267813/000110465920086497/0001104659-20-086497-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920087919/0001104659-20-087919-index.htm
2020-08-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920090463/0001104659-20-090463-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1267813/000110465920090464/0001104659-20-090464-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920093891/0001104659-20-093891-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920104612/0001104659-20-104612-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920104915/0001104659-20-104915-index.htm
2020-09-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000110465920107215/0001104659-20-107215-index.htm
2018-01-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000113777418000009/0001137774-18-000009-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000113777419000032/0001137774-19-000032-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000113777420000056/0001137774-20-000056-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000117891318000508/0001178913-18-000508-index.htm
2017-12-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000119312517373740/0001193125-17-373740-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000119312519039756/0001193125-19-039756-index.htm
2019-12-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000119312519314029/0001193125-19-314029-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000119312520036502/0001193125-20-036502-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1267813/000119380518000226/0001193805-18-000226-index.htm
2018-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1267813/000155837018001587/0001558370-18-001587-index.htm
2018-03-07DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1267813/000155837018001591/0001558370-18-001591-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000155837018001594/0001558370-18-001594-index.htm
2018-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267813/000155837018003708/0001558370-18-003708-index.htm
2018-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000155837018003710/0001558370-18-003710-index.htm
2018-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000155837018006262/0001558370-18-006262-index.htm
2018-08-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267813/000155837018006266/0001558370-18-006266-index.htm
2018-10-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267813/000155837018007973/0001558370-18-007973-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1267813/000155837018008053/0001558370-18-008053-index.htm
2019-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1267813/000155837019001860/0001558370-19-001860-index.htm
2019-03-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1267813/000155837019002404/0001558370-19-002404-index.htm
2019-03-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1267813/000155837019002439/0001558370-19-002439-index.htm
2019-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267813/000155837019003737/0001558370-19-003737-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267813/000155837019007686/0001558370-19-007686-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267813/000155837019010151/0001558370-19-010151-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1267813/000155837020002792/0001558370-20-002792-index.htm
2020-04-17PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1267813/000155837020003995/0001558370-20-003995-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1267813/000155837020004375/0001558370-20-004375-index.htm
2020-05-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267813/000155837020004979/0001558370-20-004979-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1267813/000155837020009720/0001558370-20-009720-index.htm
2020-05-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1267813/999999999520001162/9999999995-20-001162-index.htm
2020-07-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1267813/999999999520001928/9999999995-20-001928-index.htm

Marinus Pharmaceuticals, Inc (MRNS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Marinus Pharmaceuticals, Inc (MRNS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 255%
Institutional Ownership: 7112%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-12-13Scott BraunsteinChief Executive OfficerBuy100,000.001.25125,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1267813/000110465919072572/0001104659-19-072572-index.htm
2020-01-30Edward F SmithCFOSell2,380.002.054,879.0017,717.00https://www.sec.gov/Archives/edgar/data/1267813/000110465920009947/0001104659-20-009947-index.htm
2019-05-16Edward F SmithCFOSell24,211.005.03121,781.3320,097.00https://www.sec.gov/Archives/edgar/data/1267813/000110465919030563/0001104659-19-030563-index.htm
2019-01-28Christopher Michael CashmanCEOSell8,142.003.1325,484.46239,761.00https://www.sec.gov/Archives/edgar/data/1267813/000110465919004459/0001104659-19-004459-index.htm
2018-01-18Christopher Michael CashmanCEOSell9,566.006.2860,074.48247,903.00https://www.sec.gov/Archives/edgar/data/1267813/000110465918003365/0001104659-18-003365-index.htm
2019-03-18Christopher Michael CashmanCEOBuy31,662.001.0432,928.48271,423.00https://www.sec.gov/Archives/edgar/data/1267813/000110465919016364/0001104659-19-016364-index.htm
2017-12-19Bain Capital Life Sciences Investors, LLC10% Share HolderSell55,229.007.11392,429.663,977,453.00https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm
2017-12-19Bain Capital Life Sciences Investors, LLC10% Share HolderSell94,771.007.62722,240.314,032,682.00https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm
2017-12-18Bain Capital Life Sciences Investors, LLC10% Share HolderSell300,000.007.502,251,440.004,127,453.00https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm
2017-12-15Bain Capital Life Sciences Investors, LLC10% Share HolderSell102,882.008.64888,488.954,427,453.00https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm
2019-01-29Edward F SmithCFOSell2,492.003.067,625.5244,308.00https://www.sec.gov/Archives/edgar/data/1267813/000110465919004457/0001104659-19-004457-index.htm
2017-12-15Bain Capital Life Sciences Investors, LLC10% Share HolderSell719,665.008.025,770,202.004,530,335.00https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm
2018-01-29Edward F SmithCFOSell3,000.007.9123,730.0049,800.00https://www.sec.gov/Archives/edgar/data/1267813/000110465918004810/0001104659-18-004810-index.htm